The AMR Industry Alliance conducted a review of current antimicrobial resistance (AMR) research and development (R&D) and found a steep decline in the antimicrobial research workforce over the past 20 years, with only 3,000 active researchers worldwide (as of 2020). This “brain drain” is likely due to low investment in antimicrobial research, a lack of market incentives, and a loss of expertise due to job changes and retirement. Ensuring adequate public and private funding of incentives will drive AMR R&D efforts and curb the outflow of talented professionals from the field. [AMR Industry Alliance]
إرسال تعليق